Edwards Lifesciences Corporation

EW·NYSE·Healthcare
Compare
99.37+4.18 (+4.39%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market102.00+2.63 (+2.65%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close95.19
Open98.58
Day range96.72100.25
52-week range74.66100.25
Off day high−0.88%
Off 52-week high−0.88%
Volume7.86M
Avg. volume (3M)3.50M
Market cap57.28B
EPS (TTM)1.68
Forward P/E29.38
P/E ratio (TTM)59.15
Dividend yield—
Beta (5Y)0.83
Shares outstanding576.40M
Short interest1.84% of float
Earnings dateNov 4, 2026
Analyst target102.53
Profit margin15.43%

Against its peers

Compare in full ›
EW MDT 7575.T 2160.HK AORT AVR
Market cap 57.28B 134.26B 118.28B 1.63B 1.29B 596.45M
P/E (TTM) 59.1 25.8 13.1 — — —
Forward P/E 29.4 16.4 13.8 37.9 35.3 -5.3
Price/book 5.6 2.7 1.8 0.8 2.9 2.4
Dividend yield — 2.74% 3.45% — — —
1-year change +14.91% +9.38% +11.48% −77.54% −49.02% +33.02%
Today +4.39% +6.15% +3.95% 0.00% +11.56% +9.29%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.

Latest news

All EW news ›
Seeking Alpha··3 outletsPositive

Edwards Lifesciences Corporation (EW) Q3 2026 Earnings Call Transcript

Edwards Lifesciences Corporation (EW) Q3 2026 Earnings Call November 4, 2026 5:00 PM EST Gerianne Sarte - Investor Relations OfficerBernard Zovighian - CEO & DirectorTheodora Mistras - Corporate VP & CFODaniel Lippis - Corporate Vice…

More from 2 other outlets
JKN·Positive

Edwards Lifesciences Advances Over 4% Following Truist Upgrade

Edwards Lifesciences gained 4.28% on Wednesday, closing at $99.26 in New York, as investor sentiment improved following a broker upgrade. The stock added $4.07 during the session after Truist Securities raised its rating on the medical…

EW
MarketBeat··2 outletsPositive

Edwards Lifesciences (NYSE:EW) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS

View Our Latest Stock Report on Edwards Lifesciences Edwards Lifesciences Corporation NYSE: EW is a medical technology company focused on therapies for structural heart disease and critical care. The company develops and manufactures…

More from 1 other outlet
TCTMD.com·Positive

CLASP II TR: Pascal T-TEER Offers Health Status Benefits and More

SAN DIEGO, CA—Tricuspid transcatheter edge-to-edge repair (T-TEER) with the Pascal system (Edwards Lifesciences) offers better outcomes over optimal medical therapy (OMT) alone at 6 months, largely driven by differences in quality of life,…

EW

From the 4Search news index, newest first.

In the news

50mentions in 30 days
48with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 50 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance